<code id='E3D394C291'></code><style id='E3D394C291'></style>
    • <acronym id='E3D394C291'></acronym>
      <center id='E3D394C291'><center id='E3D394C291'><tfoot id='E3D394C291'></tfoot></center><abbr id='E3D394C291'><dir id='E3D394C291'><tfoot id='E3D394C291'></tfoot><noframes id='E3D394C291'>

    • <optgroup id='E3D394C291'><strike id='E3D394C291'><sup id='E3D394C291'></sup></strike><code id='E3D394C291'></code></optgroup>
        1. <b id='E3D394C291'><label id='E3D394C291'><select id='E3D394C291'><dt id='E3D394C291'><span id='E3D394C291'></span></dt></select></label></b><u id='E3D394C291'></u>
          <i id='E3D394C291'><strike id='E3D394C291'><tt id='E3D394C291'><pre id='E3D394C291'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:63865
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Novartis develops a rapidly manufactured CAR

          RubyWallauforSTATNEWORLEANS—Forsomepatientssufferingwithcertainbloodcancers,CAR-Ttherapycanofferthet